How Much Weight Do I Lose on Ozempic?

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist that reduces hunger signals and slows stomach emptying, leading to consistent weight loss in clinical trials. The amount of weight you lose depends on your starting dose, how quickly your healthcare provider increases it, your adherence to the medication, and your unique genetic response to peptide therapies. PlexusDx compounded semaglutide injections start at $149 per month and can be paired with genetic testing to identify your optimal pathway.

Average Weight Loss on Semaglutide: Clinical Trial Data

In the STEP trials, participants receiving semaglutide injections lost an average of 9.2 kg (20.2 lbs) over 16 weeks at lower doses, and up to 15.3 kg (33.7 lbs) at higher maintenance doses. By 68 weeks of continuous therapy, many patients achieved cumulative losses of 15–20% of their starting body weight. These results were significantly higher than those seen with diet and exercise alone or with placebo.

Weight loss typically follows a predictable pattern: rapid initial loss in weeks 1–4, steady weekly loss from weeks 4–12, and then a plateau phase where loss slows as your body adjusts. Starting your dose low and increasing it gradually—often called a titration schedule—helps minimize nausea while maximizing results. Most patients reach their target dose by week 8–12 of treatment.

How Dose Escalation Impacts Your Weight Loss Timeline

Semaglutide dosing begins at 0.25 mg weekly and increases in 0.25 mg increments every 4 weeks until reaching your therapeutic dose, typically 1.0–2.4 mg weekly depending on your response and tolerability. Faster dose escalation may produce quicker results but increases the risk of gastrointestinal side effects such as nausea and constipation. Slower escalation may extend the timeline but often leads to better tolerability and sustained adherence.

Your dose may need to go up. Your price won't. PlexusDx charges a flat monthly rate regardless of which week of your dose escalation you are in, ensuring transparency and predictability in your treatment costs. This pricing model encourages your provider to adjust your dose to match your individual needs without financial penalty.

Genetic Factors That Influence Your Personal Weight Loss Results

Your genetic makeup affects how effectively your body responds to semaglutide through variants in GLP-1 receptor sensitivity, appetite-regulation genes like FTO and MC4R, and metabolic rate genes. The PlexusDx Precision Peptide Genetic Test identifies 14 metabolic pathways and 49 peptide-related variants to reveal which mechanisms are most active in your body. This insight helps your clinician predict whether you will respond robustly to GLP-1 therapy or whether a dual-compound approach like tirzepatide might be more effective.

Patients with high-activity GLP-1 receptor variants (such as rs6923761) often experience faster initial weight loss and better appetite suppression at lower doses. Those with genetic variants that reduce GLP-1 sensitivity may require higher doses or longer treatment periods to achieve the same results. Testing for these pathways at $99 after your first month of treatment can guide dose optimization and prevent months of under-treatment.

Realistic Expectations: Factors Beyond Medication That Affect Outcomes

Semaglutide amplifies weight loss when combined with consistent exercise and balanced nutrition, but medication alone produces meaningful results in most patients. Studies show that participants who added a structured exercise program (150 minutes per week) and reduced calorie intake lost 5–10% more body weight than those relying on medication only. Sleep quality, stress management, and adherence to your injection schedule also play supporting roles in your overall progress.

Weight loss plateaus are normal and typically occur after 12–16 weeks as your body adapts to the medication. Plateaus do not mean the treatment has stopped working; they reflect a new equilibrium where your appetite suppression has stabilized. Continuing your dose, adjusting your nutrition slightly, or increasing exercise intensity can help break through plateaus. Some patients require dose increases beyond the standard range to maintain momentum, which remains the same price through PlexusDx's flat-rate model.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose in the first month on semaglutide?

Most patients lose 2–4 lbs in the first 4 weeks, primarily through reduced appetite and water loss. This initial loss accelerates during weeks 4–12 as your dose increases and your body fully responds to the medication. Individual results vary based on starting dose, baseline weight, and adherence.

Is semaglutide weight loss permanent after you stop taking it?

Clinical data shows that weight regains approximately 50% of lost pounds within 1 year after stopping semaglutide, though some patients maintain significant portions of their loss through lifestyle changes. Ongoing medication is often necessary to sustain results long-term. PlexusDx provides continuous compounded semaglutide at $149/month to support maintenance of your achieved weight loss.

Can I lose 50 pounds or more on semaglutide?

Yes, patients with higher starting weights and consistent adherence often achieve 40–70+ pound losses over 12–18 months. Loss magnitude depends on your starting body weight, genetic response, dose achieved, and lifestyle habits. The PlexusDx Precision Peptide Genetic Test can reveal whether your metabolism favors sustained high responder status.

What if I'm not losing weight on semaglutide?

Non-response may indicate insufficient dosing, genetic variants that reduce GLP-1 sensitivity, or underlying metabolic factors unrelated to appetite suppression. The PlexusDx Precision Peptide Genetic Test identifies MC4R and FTO variants that predict treatment response and can guide a switch to dual-compound therapy like GLP-Squared. Consultation with your clinician is essential before adjusting treatment.

Does the PlexusDx Precision Peptide Genetic Test predict how much weight I'll lose?

The test identifies your genetic predispositions across GLP-1R, GIPR, FTO, and MC4R pathways, which helps predict your likelihood of being a high responder versus a moderate responder. It does not predict an exact weight loss number but rather guides your provider toward the most suitable medication, starting dose, and escalation strategy. Testing costs $99 after your first month of compounded semaglutide treatment.

Related Reading

• Ozempic For Losing Weight
• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.